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Abstract 
Nødtvedt A. 2007. Epidemiology of canine atopic dermatitis. Doctoral thesis. 
ISSN 1652-6880, ISBN 978-91-576-7346-6 
 
Canine atopic dermatitis (CAD) is a chronic, allergic skin disease associated with IgE-
mediated reactions to environmental allergens. Atopic dermatitis/eczema in humans shares 
many similarities with CAD and is an increasing problem in industrialized countries. This 
increase has been attributed to lifestyle and environment factors. The current knowledge 
about the epidemiology of CAD is limited. The aim of this thesis was therefore to 
investigate the incidence of and potential risk factors for the development of CAD. 
Three of the included studies involve the use of a large animal-insurance database. The 
database includes information about a large number of healthy and diseased individuals 
over time, but it was not collected for research purposes and data-quality issues needed to 
be addressed. A validation of the diagnosis CAD in the insurance database showed that 
although the vast majority of the recorded cases could be considered allergic, the important 
differential diagnosis cutaneous adverse food reactions had not been ruled out for many 
patients. The overall incidence rate of CAD was 1.7 cases per 1000 dog years at risk. 
Several factors were found to be associated with an increased risk of CAD in the insured 
population; living in an urban area or in the south of Sweden, being born in the autumn and 
belonging to a high-risk breed. Furthermore, a spatial analysis showed that the incidence of 
CAD increased by increasing human population density and increasing annual rainfall, and 
was decreased in the north of Sweden and if there was no veterinary dermatologist present 
in the county. Finally, a case-control study was performed where 12 veterinarians collected 
CAD cases from the three identified high-risk breeds; boxer, bullterrier and West Highland 
white terrier. The main finding was that feeding a diet containing home-made/ non-
commercial ingredients to the bitch during lactation protected her offspring from 
developing CAD. 
In conclusion, a strong breed predisposition for CAD was seen. Evidence of an increased 
incidence of CAD in densely populated areas exists but might be biased by the locations of 
veterinary dermatologists. The potential of using diet for primary prevention of CAD is 
interesting but randomized controlled clinical trials are required to support this finding. 
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AD  Atopic dermatitis  
CAD  Canine atopic dermatitis 
CAFR  Cutaneous adverse food reactions 
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DYAR  Dog years at risk 
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IR Incidence  rate 
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TH1  Type 1 helper T cells 
TH2  Type 2 helper T cells 
WHWT  West Highland white terrier   9 
Background 
Canine atopic dermatitis 
Canine atopic dermatitis (CAD) has been defined as “a genetically-predisposed 
inflammatory and pruritic allergic skin disease with characteristic clinical features 
(…) associated most commonly with IgE antibodies to environmental allergens” 
(Olivry et al., 2001). In Sweden, as well as in many other European countries, the 
most frequently reported allergen reactions among dogs with CAD are towards 
house dust mites (HDM) (Öhlén, 1992; Saridomichelakis et al., 1999). Other 
groups of allergens in CAD-positive dogs include epithelia, pollens, moulds, dusts 
and feathers. 
 
Atopic dermatitis was first reported in a dog 65 years ago, and received 
increasing attention in the later half of the 20
th century (Griffin & DeBoer, 2001). 
Despite of this continuing interest, many issues remain unresolved regarding the 
clinical manifestations, diagnosis, occurrence and pre-disposing factors for CAD. 
 
Clinical manifestations 
Pruritus is the main clinical manifestation of CAD, and it typically affects the face, 
ears, paws, extremities, axillae and/or ventrum (Griffin & DeBoer, 2001). The 
extent of primary lesions involved in CAD is somewhat unclear, although the 
presence of erythema appears to be generally accepted (Hillier & Olivry, 2004). 
Marsella et al. (2006) report that high-IgE responder beagles which had been 
epicutaneously sensitized to HDM developed papular eruptions in addition to 
pruritus and erythema following environmental allergen challenge. The severity of 
the lesions was dose-dependent and reportedly mimicked those in privately owned 
patients with CAD, and this was taken as an indication that these were primary 
lesions (Marsella et al., 2006). Reported secondary lesions of CAD include self-
induced effects of licking and scratching such as salivary staining, excoriations 
and alopecia. Scaling, hyperpigmentation and dry lustreless hair-coat are other 
common findings. Furthermore, otitis externa and secondary bacterial infections 
are typical features of CAD patients and conjunctivitis has also been described in 
many cases. The typical time of onset for CAD is between six months and three 
years of age, and most affected dogs will eventually develop non-seasonal clinical 
signs even though the disease episodes can be seasonal initially (Griffin & 
DeBoer, 2001). 
 
Diagnosis 
No definitive diagnostic test exists for CAD and the diagnosis is instead based 
upon the typical clinical presentation after exclusion of relevant differential 
diagnoses. A list of minor and major criteria for the diagnosis was proposed in the 
1980s, inspired by similar lists used for the diagnosis of human atopic dermatitis 
(Willemse, 1986). The criteria proposed by Willemse (1986) have been widely 
used by veterinary dermatologists when diagnosing CAD, but have not been   10
formally evaluated in terms of sensitivity and specificity. It has been argued that 
neither these nor any other proposed checklists of clinical criteria are perfect, and 
that the only way of confirming a state of hypersensitivity is by provocative 
testing using offending allergens in affected patients (DeBoer & Hillier, 2001a). 
This is not feasible in a clinical setting, but it should be kept in mind that the 
diagnosis CAD needs to be based on careful evaluation of the patient and 
elimination of other causes of pruritus and not on a single feature or test. 
 
An important point regarding the disease is that dogs can react to ingested food 
with clinical signs that are indistinguishable from those of CAD. Many dogs that 
react to food with pruritus and inflammation of the skin do not have IgE-mediated 
hypersensitivity towards ingested proteins, and the disease complex is termed 
cutaneous adverse food reactions (CAFR) due to an uncertainty regarding 
pathogenesis (Hillier & Griffin, 2001a). The diagnosis of CAFR is ruled out by 
performing a hypoallergenic diet trial followed by rechallenge, which needs to be 
done before a diagnosis of CAD can be established (Griffin & DeBoer, 2001). The 
exact relationship between CAD and CAFR is unclear, but several studies report 
that a fraction of dogs with CAD (3 – 13%) have concurrent CAFR (Hillier & 
Olivry, 2004). 
 
Once the diagnosis of CAD has been established it is often of interest to 
determine which specific allergens a patient reacts towards. This is done by either 
serum-based (DeBoer & Hillier, 2001b) or intradermal allergy tests (Hillier & 
DeBoer, 2001). The aim of the allergen identification testing is to select allergens 
for immunotherapy or allergen avoidance, and it has been repeatedly emphasized 
that these tests are not useful for the initial clinical diagnosis of CAD because even 
clinically healthy animals can display positive reactions (DeBoer & Hillier, 
2001a). More recently, Hillier and Olivry (2004) suggested that the diagnosis of 
CAD should be based on the following criteria: 
1.  Clinical features: pruritus and skin lesions affecting any of the following 
body sites: face, ears, ventral trunk (especially axillae and groin) and/or 
distal limbs. 
2.  Elimination of differential diagnoses: flea allergy dermatitis, CAFR, 
sarcoptic acariasis, other pruritic mite infestations, Staphylococcal 
dermatitis and Malassezia dermatitis. 
3.  Supplementation of allergy tests: positive reactions on intradermal testing 
or with IgE specific serology should be an aid in clinical management of 
cases, but not form the basis of the diagnosis. 
These criteria might be more practical from a clinical perspective than the criteria 
proposed by Willemse (1986), but also lack documentation in terms of sensitivity, 
specificity and predictive ability. 
 
Occurrence 
The incidence and prevalence of CAD are both unknown. A prevalence of about 3 
to 15% of the general population has been suggested, but these estimates are not 
based on reliable epidemiological data (Hillier & Griffin, 2001b). Some studies 
have related the number of CAD cases to all dermatology complaints in various   11 
kinds of veterinary practice, as this will give a general impression of how common 
the problem is. Hillier and Griffin (2001b) reviewed the literature and found that 
between 3.3% and 30% of all cases with skin disease were reported to have CAD, 
depending on the type of practice studied. Not surprisingly, the proportion of CAD 
positive dogs tended to be higher in dermatology referral clinics than in general 
practice. 
 
Estimating the incidence and prevalence of CAD is complicated by the fact that 
mild cases of disease are likely to be treated symptomatically, without the owner 
(or veterinarian) being aware of the underlying disease. The same problem of 
misclassification might apply to patients with recurrent otitis externa or bacterial 
dermatitis as the main presenting complaint. Finally, the lack of uniformly defined 
diagnostic criteria for CAD makes reliable and reproducable studies of the disease 
difficult to perform (Hillier & Olivry, 2004). 
 
Pre-disposing factors 
Gender predilections for CAD have been reported for both males and females, and 
whether a difference in disposition between genders exist remains unresolved 
(Griffin & DeBoer, 2001). 
 
It is generally accepted that there is a genetic predisposition to CAD, because 
the disease is seen more commonly within certain breeds (Sousa & Marsella, 
2001). The reported high-risk breeds vary between study populations and 
geographical regions. This might reflect genetic differences between regional dog 
populations but might also be an artefact because many studies do not take the 
distribution of breeds in the underlying population at risk into account. Sousa and 
Marsella (2001) compared reported high-risk breeds from ten different studies, 
and both the West Highland white terrier (WHWT) and boxer were reported to be 
at increased risk in several studies as were, among others, Labrador and golden 
retrievers. 
 
In a British study, the heritability of CAD was estimated to be 0.47 in 32 litters 
of (mainly) Labrador and golden retrievers, suggesting that the genetic 
background contributed around 50% of the variability of disease occurrence 
(Shaw et al., 2004). It should be noted that these dogs were all from the “Guide 
dogs for the blind association”, and hence subject to fairly consistent management 
practices during their first two years of life. In a study of 33 litters of privately 
owned WHWTs, no clear pattern of heritability was detected but a tendency of 
CAD positive puppies to cluster within litters was observed (DeBoer & Hill, 
1999). Even though genetic predisposition seems to be an important underlying 
feature for CAD, allergen exposure in combination with multiple flare factors is 
needed for clinical signs to develop (Hillier & Olivry, 2004). Because not all 
predisposed individuals develop CAD, the influence of environmental factors in 
the natural history of the disease cannot be ignored. 
 
A threshold effect for clinical signs has been observed in affected cases of CAD, 
where a summation of pruritic stimuli appears to be needed for signs to occur   12
(Marsella & Sousa, 2001). Hence, an individual who is sensitized towards both 
HDM and pollen can be asymptomatic during long periods of the year because the 
mites alone are not enough to trigger pruritus. During pollen season however, the 
threshold might be crossed and the patient displays clinical signs of CAD. Other 
factors that can potentially contribute to an affected dog reaching its “pruritic 
threshold” are concurrent CAFR, flea bite dermatitis, secondary skin infections 
and environmental factors such as humidity and/or temperature. Furthermore, the 
“pruritic threshold” will vary between individuals and could potentially be 
lowered by stress (Marsella & Sousa, 2001). 
 
Prevention 
If the purpose of investigating predisposing factors of CAD is to develop the 
means prevent disease, it is important to distinguish between primary and 
secondary prevention. Primary prevention aims at hindering the disease from 
developing in an individual and secondary at reducing clinical signs in affected 
patients (Arshad, 2005). A means of primary prevention in the canine population 
could be to avoid breeding CAD positive dogs, but this is complicated by the fact 
that the disease can debut after sexual maturity. If dogs at high risk of developing 
allergic disease could be detected through a diagnostic test at young age these 
individuals could be excluded from the breeding pool. Elevated chord blood levels 
of IgE in newborns have shown correlation to future development of allergy in 
humans, although the predictive value of the IgE level alone is weak (Allam et al., 
2005). Regardless of CAD status, puppies have been reported to have low and 
adult dogs to have very high levels of plasma IgE (Ledin et al., 2006). 
Furthermore, no correlation between total serum IgE levels in young puppies and 
subsequent development of clinical signs of allergy has been detected in dogs and 
such testing is therefore of little diagnostic value (DeBoer & Hill, 1999). Genetic 
testing for early detection of atopic susceptibility is currently not available for 
neither canines nor humans, but could present a powerful tool for the development 
of prevention strategies in the future. 
 
Clinical relevance 
CAD is a chronic disease that affects an unknown number of dogs. It will cause 
variable degrees of discomfort in affected individuals, who are also prone to other 
dermatological problems such as secondary skin infections and otitis externa. 
Understanding the epidemiology of CAD, including disease frequency and major 
risk factors, is important to veterinarians striving for better clinical management of 
affected cases as well as for owners and breeders aiming at prevention of the 
disease. 
 
Atopic dermatitis in humans 
In the human literature, atopy has been defined as a genetic propensity to produce 
IgE antibodies after exposure to allergen, and allergy as clinical manifestations of 
immunologically mediated reactions to foreign substances (Arshad, 2005). Some 
of the clinical manifestations of allergy are asthma, allergic rhinitis, food allergies   13 
and atopic dermatitis/eczema. Atopic patients tend to develop a spectrum of these 
manifestations through time. Typically, affected infants will display eczematous 
skin and gastrointestinal symptoms followed by asthma and rhinitis to inhalant 
allergens later in life. This time-dependent development has been termed “the 
atopic march” (Johansson et al., 2001). 
 
Pre-disposing factors 
There has been a considerable increase in the prevalence of AD among children in 
industrialized countries over the past few decades (Leung & Bieber, 2003). Due to 
the high prevalence, the disease is a substantial public health problem in addition 
to its negative effects in affected families. Williams (2000) reviewed the 
epidemiology of AD and found the disease to be slightly more common in female 
children. Furthermore, a higher prevalence of AD has been seen with higher socio-
economic status and smaller family size, which has been taken to suggest that a 
“western lifestyle” is responsible for the observed increase in prevalence. In a 
worldwide, cross-sectional questionnaire survey of the prevalence of AD, 
symptoms of the disease were found to be more common in Australasia and 
Northern Europe while the prevalence was lower in Eastern and Central Europe 
and Asia (Williams et al., 1999). Although there is a genetic background for the 
disease, it seems unlikely that the increasing prevalence in western, industrialized 
countries should be due to a shift in genetic make-up. Consequently, several 
authors point out that the increasing prevalence of manifestations of AD must be 
due to interactions between genes and the environment (Williams, 2000). 
 
Rural living has been reported as a protective factor against the development of 
allergies in children in various studies (such as by Alfven et al., 2006). Factors that 
might contribute to a higher prevalence of allergies among children living in cities 
are differences in environmental exposure to air pollution, home heating and 
allergens or lifestyle factors such as smaller family size and lower levels of 
exposure to livestock than in rural areas (Naleway, 2004). A recent cross-sectional 
study showed that consumption of unpasteurized milk had a protective effect 
against the development of AD and allergic sensitization in British children living 
in a rural environment (Perkin & Strachan, 2006). Perkin and Strachan (2006) 
conclude that farm living in itself does not affect the prevalence of AD, and 
suggest that the protective effect of rural living seen in other studies might be 
mediated through consumption of unpasteurized milk. In a comparison of Swedish 
and Estonian children, the observation was made that the prevalence of AD was 
lower, while circulating IgE antibodies more common, among the latter group 
(Voor et al., 2005). The authors speculate that the observed difference in 
prevalence could be due to Estonian children having more contact with various 
micro-organisms in early life, and hence a different development of the immune 
system as compared to children in Sweden. 
 
Immunology and “The hygiene hypothesis” 
The so-called “hygiene hypothesis” was proposed by Strachan (1989), and the 
basic principle is that microbial exposure in early life influences the immune   14
system in a way that provides protection against the development of atopic 
reactions. The hypothesis is that the higher prevalence of allergic diseases, 
including AD, seen with decreasing family size could be due to fewer cross-
infections from older siblings during childhood (Strachan, 1989). The rationale 
behind the “hygiene hypothesis” is that exposure to microbes will promote cell-
mediated immunity and type 1 helper T cells (TH1), while the humoral immunity 
seen in newborns and dominated by type 2 helper T cells (TH2) is down-regulated. 
TH1 cells are associated with response to infection while TH2 are typically 
involved in allergic reactions mediated by cytokines that stimulate production of 
IgE and maturation of mast cells, eosinophils and basophils (Leung & Bieber, 
2003). Recently, a more balanced view on the relationship between TH1 and TH2 
responses in allergy has emerged, and the importance of T regulatory cells in the 
control of allergen-specific immune responses through the suppression of both 
lines has been documented (Akdis, Blaser & Akdis, 2005). In a review of the 
existing literature regarding AD and the hygiene hypothesis, Flohr et al. (2005) 
conclude that no specific pathogen appears to be linked to the “allergic”/ TH2-
dominated immune-response. Rather, the authors suggest that the reported 
protective effects associated with early attendance at day-care, endotoxin and 
animal exposure are due to non-pathogenic microbial stimuli over time (Flohr, 
Pascoe & Williams, 2005). Alterations in gut microflora, specifically through 
increased colonisation with lactobacilli, is proposed as an immunomodulatory 
mechanism that will suppress the TH2 response through the pathway of T 
regulatory cells (Baker, 2006). This has given rise to new research where dietary 
supplementation of probiotics (=live microbial food supplements with proved 
beneficial effect on human health) in infancy has yielded decreased prevalence of 
AD (Rautava, Kalliomaki & Isolauri, 2005). 
 
Comparison between canine and human atopic dermatitis 
Canine atopic dermatitis shares many similarities with the disease in humans. 
Pruritus is the main clinical sign in both species, combined with a familiar or 
hereditary predisposition and a limited extent of primary lesions (Rhodes, Kerdel 
& Soter, 1987). Furthermore, affected individuals from both species are 
susceptible to secondary skin infections and display similar histopathological 
features. House dust mites, in particular the species Dermatophagoides farinae 
and D. pteronyssinus, appear to be the most important indoor allergens in both 
species even though the specific peptides involved in the allergen reactions differ 
(Nuttall et al., 2006). CAD is a chronic disease, while an unknown proportion of 
human patients go into complete remission in their early teens. However, children 
with AD are at increased risk of developing respiratory allergies as well as skin 
disease later on in life (Thestrup-Pedersen, 2000). This so-called “atopic march” 
seen in human patients is not a documented feature of CAD. It should also be 
noted that two types of AD are described in the literature. The extrinsic type is 
associated with IgE and is most common, while the intrinsic type has no IgE 
mediated sensitisation (Leung & Bieber, 2003). Whether these two variants of AD 
differ in terms of severity, response to treatment or subsequent development of 
asthma is not known (Williams & Flohr, 2006). Other authors argue that non-IgE   15 
mediated dermatitis should not be termed atopic in the first place, and some 
controversy exists regarding the nomenclature (Johansson et al., 2001). For the 
vast majority of patients with CAD, allergen-specific IgE can be demonstrated 
either by intradermal testing or by IgE serology. 
 
Due to the many similarities, CAD can potentially serve as a spontaneous model 
for AD in humans and thereby increase our knowledge regarding the disease in 
this species (Hillier & Olivry, 2004). However, little is currently known about the 
epidemiology of CAD due to the problems discussed previously; few reliable 
studies, lack of uniform diagnostic criteria and possible misclassification bias. It is 
therefore of interest to perform studies aimed at determining if similarities exist 
between the epidemiology of atopic dermatitis among the two species. An overall 
aim of this thesis was to perform investigations into the incidence of and risk 
factors for CAD. It is further of interest to compare the findings to what is known 
about the epidemiology of AD in humans in order to evaluate the usefulness of 
this “canine model” for future comparative studies. 
 
Estimating disease frequency in companion animals 
Unfortunately, a great deal of confusion regarding the terms incidence and 
prevalence exists in the veterinary literature. Due to limitations in study quality 
and availability, neither the prevalence in a general population nor the incidence of 
CAD is currently known (Hillier & Griffin, 2001b). 
 
Measures of disease frequency 
Incidence rate (IR) measures the number of new disease cases in a population per 
animal-time unit at risk (Dohoo, Martin, & Stryhn, 2003a). The time units can be 
expressed as dog-years/months/days at risk, and because they can be selected 
arbitrarily the numerical value of the IR has no direct interpretation. Incidence 
rates are used when the aim of a study is to evaluate what factors are related to a 
disease. The individuals who contribute time to the denominator of an IR are 
referred to as the “population at risk” (Rothman & Greenland, 1998a). For a 
chronic disease such as CAD, an individual will no longer contribute time at risk 
to the denominator after the disease has been recorded because CAD can only 
emerge once in an animal’s lifetime. The incidence risk, also known as cumulative 
incidence or incidence proportion, is the probability that an individual will 
develop a disease within a defined time period (Dohoo, Martin & Stryhn, 2003a). 
This measure is used when the objective of a study is to make individual 
predictions about disease occurrence. 
 
Prevalence can be defined as the proportion of a population that has a disease at 
a specific point in time (Rothman & Greenland, 1998a). The prevalence of a 
disease is a function of its duration and incidence, and a disease with high 
incidence can have low prevalence if it is rapidly fatal. Prevalence is less useful 
than IR in evaluating risk factors for disease because it is affected by factors that 
contribute to either disease occurrence or duration (Dohoo, Martin, & Stryhn,   16
2003a). Because CAD is a chronic disease that rarely kills the affected individual, 
its incidence is expected to be lower than the prevalence in a stable population. 
 
Sources of population data for companion animals 
Prevalence is calculated by dividing the number of diseased individuals with the 
total number in the population at the same point in time, while animal time-units at 
risk in the population constitute the denominator in the IR. The calculated measure 
of disease frequency therefore depends on the available study population. In 
general, IRs are rarely calculated in companion animal studies because the time at 
risk contributed by each individual in the studied population is seldom known. 
Studies of disease frequency in companion animals are often based on already 
existing data with its given limitations regarding quality, completeness and 
representability. Some recent examples of both primary (collected for research 
purposes) and secondary (already existing) sources of data for measures of disease 
frequency and risk factors among companion animals are presented below. 
 
Primary data collection 
Incidence rate calculations can be performed through cohort (or their variant 
longitudinal) studies, in which a group of presumably healthy individuals are 
followed over time to see who develops the disease in question (Dohoo, Martin, & 
Stryhn, 2003b). The IR of canine mammary tumours among three dog breeds in 
Norway was estimated by combining information from diagnostic tumour 
submissions and a census of dog owners of the breeds Bernese mountain dog, 
boxer and bichon frisé (Moe, 2001). Overall, cohort studies are rare in companion 
animal epidemiology. 
 
In cross-sectional studies, exposure and disease status for a sample of subjects 
are determined at a given time and the obtained measure of disease frequency is 
the prevalence. This design is frequently applied in veterinary epidemiology 
(Dohoo, Martin, & Stryhn, 2003c). A questionnaire aiming at determining disease 
prevalence among purebred dogs in Denmark is an example of a cross-sectional 
study (Proschowsky, Rugbjerg & Ersboll, 2003). The response-rate was low in 
this study and the representativness of the underlying population at risk unknown. 
It was concluded that diseases of the skin and ears were breed-dependent and 
affected 13.6% and 13.2% of the included dogs, respectively. Serological 
investigations in a group of animals are also examples of cross-sectional studies 
that will yield a prevalence of sero-positive individuals at the time of sampling 
(sero-prevalence). In a recent survey, the sero-prevalence of canine babesiosis and 
ehrlichiosis was determined at a veterinary teaching hospital in Brazil by testing a 
systematic random sample of its patients (Trapp et al., 2006). 
 
Secondary databases 
Other sources of information about canine populations are secondary databases, 
which contain data that was not originally collected for research purposes. Disease 
recordings from veterinary hospitals have been used extensively for these kinds of 
studies, and authors have collected information about diagnosis and animal   17 
attributes from both single hospitals and combinations of hospitals in larger 
databases. Even for the larger studies there is a lack of knowledge about the 
population at risk, because only animals that come into the hospital are recorded 
and the underlying number of dogs that could give rise to the recorded cases 
remains unknown. However, these studies can be used to calculate hospital based 
prevalence of disease and to determine if for instance some breeds are over-
represented with a diagnosis as compared to the general hospital population. In a 
recent study including 3707 small animal consultations from 20 general practices 
in the UK, 21.4 % involved a dermatological diagnosis and 4.7% of the dogs with 
a specific dermatological diagnosis were reported to have CAD (Hill et al., 2006). 
From a large study of 52 private veterinary practices in the US, the prevalence of 
CAD was reported to be 3.1 % among 31,484 examined dogs (Lund et al., 1999). 
 
Claims records from animal insurance companies constitute a less commonly 
used source of secondary data on canine populations. The main advantage of these 
databases is that information on entry, exit, disease status and more (such as breed, 
gender, date of birth, postal address) for a large number of healthy dogs is 
included. Because the time at risk contributed by each individual is known, IR 
calculations can be performed. Data on insurance claims from a UK company was 
used to calculate the IR of canine neoplasia (Dobson et al., 2002). The incidence 
was age-standardized based on a survey of the general canine population because 
the insured dogs in general were younger, and more often pure-bred, than the 
background population of dogs in the country. 
 
Several studies have been published in which the claims database from Agria 
(www.agria.se), the main Swedish insurance company to offer veterinary care and 
life insurance for animals, has been used to study general as well as disease 
specific morbidity and mortality among Swedish dogs. Two specific examples are 
a study on breed risk of pyometra (Egenvall et al., 2001) and the incidence of 
mammary tumours among bitches (Egenvall et al., 2005). The skin (and 
integument) has been reported as the most commonly affected organ system for 
veterinary care claims in the database, with a total of 3.15 % of dogs having a 
reimbursed claim pertaining to this system during 1996 (Egenvall et al., 2000a). 
 
This dissertation contains two studies of the incidence of and risk factors for 
CAD among Swedish dogs insured by Agria. It is important that issues regarding 
data quality are addressed when secondary databases are used to measure disease 
frequency, because the data were not specifically collected for this purpose. 
Furthermore, the representativness of the study population in relation to a broader 
group of animals should be evaluated. Assessing the data quality of the diagnosis 
CAD in the insurance database was among the specific aims of this thesis.   18
Aims 
The overall aim of this work has been to increase the knowledge regarding the 
epidemiology of canine atopic dermatitis. By gaining further insight into the 
occurrence of, and risk factors for, the disease it will hopefully be possible to 
provide better care for affected individuals. Ultimately, a goal could be to reduce 
the incidence of CAD. 
 
The following specific aims were set: 
 
•  To validate the correctness of the diagnosis CAD in a Swedish animal insurance 
database (I). 
 
•  To estimate the incidence rate of CAD among insured Swedish dogs (II). 
 
• To identify high-risk breeds for CAD, as well as to quantify the importance of 
the risk factors age, gender, season of birth and geographic location (II). 
 
• To analyze the spatial distribution of CAD cases in Sweden and relate spatial 
patterns to environmental risk factors for the disease (III). 
 
• To identify predisposing factors for the development of CAD in the three high-
risk breeds boxer, bullterrier and West Highland white terrier (IV).   19 
Methodological considerations 
Overall issues regarding the methods applied in paper I – IV are outlined in this 
section. For detailed descriptions of materials and methods, the reader is referred 
to each individual paper.  
 
Study populations 
Two different populations were studied regarding the epidemiology of CAD; a 
secondary database obtained from the Swedish animal insurance company Agria (I 
– III) and a prospectively collected case-control material (IV). The special 
characteristics of each population and implications for the performed studies are 
presented in the two following sections: 
 
Insured population 
The Swedish canine population is unique in that an estimated 70 percent of the 
animals are covered by an insurance plan for veterinary care and/or life, and that 
the largest insurance company (Agria) covers approximately 30 percent of the 
entire population (Egenvall et al., 1999). Egenvall et al. (1999) further conclude 
that the insured population is representative of the general canine population with 
the exception that mixed breeds and older dogs are less likely to be covered by an 
insurance plan. The quality of the diagnostic information included in this 
secondary database has been validated against practice records and deemed 
acceptable for research purposes (Egenvall et al., 1998). 
 
The study population in papers I to III consists of dogs insured by Agria. The 
target (or reference) population to which the results are to be extrapolated is the 
general Swedish canine population, keeping in mind that the under-representation 
of older dogs and mixed breeds might negatively affect the ability to extrapolate 
from study to target population (defined as internal validity by Dohoo, Martin, & 
Stryhn, 2003d). This under-representation might not be a major problem when 
studying CAD because it is a diagnosis of young animals with a breed 
predisposition affecting mainly pure-bred dogs. External validity is defined by 
Dohoo, Martin & Stryhn (2003d) as the ability to extrapolate results to an even 
wider general population, beyond the target population of Swedish dogs. In this 
case, the general population could be other national dog populations. The genetic 
make-up of pure-bred dogs can differ between geographic regions and the high-
risk breeds reported from the insured Swedish dogs might not be the same breeds 
as are seen in other countries. 
 
An advantage of using the insured population when studying disease frequency 
and risk factors is that longitudinal information on a large number of (presumably) 
healthy dogs is available. Because the time of death is known for many 
individuals, survival after diagnosis can also be calculated. Due to the large size of 
the study sample (>220,000 dogs in papers II and III) the power to detect   20
differences in risk is higher than in many smaller studies. A disadvantage is that 
only information included in the database is available, and this is often quite 
limited as the data were not originally collected for research purposes. 
Furthermore, only treatments which exceed the set deductible will be eligible for 
reimbursement and hence generate a recorded diagnosis. This will contribute to an 
underestimation of the occurrence for diseases that do not require costly 
treatments or diagnostic work-ups. 
 
Case-control population 
In paper IV, a prospectively collected case-control material was analysed. Three 
high-risk breeds for CAD were identified in the insured population (II) and 
confirmed by the literature; boxer, bullterrier and WHWT. Cases of CAD from 
these three breeds were collected by 12 veterinary dermatologists in Sweden, and 
non-affected controls matched by breed and year of birth were selected randomly 
from the Swedish Kennel Club’s (SKC) registry. Standardized inclusion and 
exclusion criteria were applied in order to ensure uniformly defined cases. 
Information about each individual dog was collected from four sources; the SKC 
registry, owner questionnaires, clinical observations by the investigating 
veterinarian and a telephone-questionnaire to the dogs breeder. Furthermore, blood 
samples were collected for genetic analysis. 
 
The main advantage of collecting this specific material was that the inclusion 
and exclusion criteria could be defined to ascertain the CAD status for all cases 
and controls. By retrieving information on early rearing from the breeders, risk 
factors that preceded the development of CAD in time could be recorded. This 
allows for claims of causality, which is usually not the case in cross-sectional and 
case-control studies where data on outcome and exposure are collected at the same 
time. A disadvantage of the design is that no inference can be drawn about the 
effect of breed or age on the risk of CAD, because these were used as matching 
variables. One might speculate that the owners and breeders of CAD cases could 
be more likely to remember exposures in the past that could be related to the 
development of the disease, also known as recall bias (Rothman & Greenland, 
1998b). This was sought minimized by having both the interviewer and the 
breeder blinded to case-status when the telephone interviews were performed. 
 
Validation of the diagnosis CAD among insured dogs (I) 
A subset of the CAD cases in the insured population studied in papers II and III 
was chosen for a validation of the diagnosis in the Agria database. Letters 
requesting medical records from all reimbursed CAD cases during 2002 were sent 
out to the attending veterinarians, unless a full medical record was available in the 
insurance company archive. The assumption was that the diagnostic criteria 
applied in the field had not changed substantially through the years 1995 to 2002, 
which was the included time-span for the analyses in papers II and III. The 
diagnosis was validated based upon available information from the collected 
medical records. Each individual was classified on an eight-point “CAD-scale” by   21 
the principal investigator, reflecting how “correct” the diagnosis was considered 
compared to the pre-set diagnostic criteria. 
 
Incidence rate calculation (II) 
The IR of CAD was calculated using exact denominators, because the time at risk 
contributed by all insured dogs was known. In addition to the overall incidence, 
the IR stratified by variables recorded in the insurance database could be 
calculated (ie IR by gender, breed, geographic region, age, year and season of 
birth). Furthermore, the proportion CAD cases out of all dogs with dermatology 
claims was estimated to allow comparisons with other published studies. 
 
Risk factor analyses (II, III, IV) 
Individual dog-level risk factors for CAD were investigated among the insured 
population as well as in the collected case-control material. Furthermore, the IR of 
CAD was aggregated by postal-code area (PCA) and geographical risk factors 
were studied through spatial analysis. In the three different regression analyses 
performed, lack of independence between observations was taken into account 
using various techniques. The dependence was created by dogs belonging to the 
same breed (II), living in neighbouring PCAs (III) or being examined by the same 
veterinary practitioner (IV). 
 
Cox regression with a random error term (II) 
Time until development of CAD was studied using a Cox proportional hazards 
model in paper II. The rationale behind applying the regression model was to be 
able to simultaneously control for several risk factors for CAD, and to determine 
their relative importance. Breed is a well established risk factor for the disease and 
had to be included in the model. Because the analyzed dataset included 130 
different breeds, it was not practical to include a separate fixed effect for each 
breed in the model. Breed was instead included as a random effect, or shared 
frailty term (Dohoo, Martin, & Stryhn, 2003e). This implies that individuals 
belonging to the same breed were not independent of each other but rather 
considered at similar risk of developing CAD; they were equally “frail”. After 
building the final proportional hazards model, a ranking of breed frailties was 
produced and compared to the crude ranking of breed-risk of CAD based on IR. 
 
Spatial analysis (III) 
Spatial analysis typically consists of the three steps visualization, exploration and 
modelling (Pfeiffer, 2004). For paper III, the IR of CAD among insured Swedish 
dogs was aggregated by PCA and initially visualized as a choropleth map. 
Spatially smoothed empirical Bayes (EB) incidence rates were subsequently 
calculated to minimize the effect of small sample size in some areas (Bailey & 
Gatrell, 1995). The presence of areas of increased or decreased risk was evaluated 
using global (Moran’s I) and local indicators of spatial association (LISA)   22
(Anselin, 1995). Finally, environmental risk factors were explored and a “risk 
map” was produced utilizing a spatial Poisson regression model (SAS, 2005). The 
model uses the x and y coordinates of the PCA centroids as a random error term to 
take the lack of independence between neighbouring areas into account. If there is 
a geographic pattern in the occurrence of CAD, it seems likely that observations 
that are close to each other in space would be more similar than observations that 
are further apart. 
 
Logistic regression with random effects (IV) 
A logistic regression model was used to investigate risk factors for CAD in the 
case-control study reported in paper IV. Forty different veterinarians were 
involved in the data collection and each contributed between one and 22 dogs to 
the study. Dogs that were recruited from the same veterinary practice were likely 
to share certain attributes, such as urban versus rural living, and examining 
veterinarian was therefore added to the logistic regression model as a random 
effect. The variable was not truly random because the 12 “main” veterinarians 
were selected based on their interest and expertise in veterinary dermatology. 
However, it was not deemed practical (nor relevant) to include 40 fixed effects for 
veterinarian in the model as these were nuisance parameters and not the focus of 
the analysis. Furthermore, examining veterinarians with only one dog included in 
the study were grouped together in the random effects model (n=27) and hence 
assumed to be the same. This is obviously a simplification, as large individual 
differences might exist within this group. 
 
Results and discussion 
The importance of eliminating adverse food reactions (I) 
The practice records obtained in paper I were compared to a slightly modified 
version of Willemse’s (1986) criteria for CAD. The modification was justified by 
the fact that none of the suggested clinical criteria are considered perfect, and as 
long as transparency exists as to which criteria were applied it is still possible to 
compare results between studies. Of the scrutinized cases, all were recorded by the 
submitting veterinarian to be suffering from CAD and 98% were judged by the 
principal investigator as having allergic skin disease. However, for a large number 
of dogs CAFR had not been properly ruled out and in total it was suggested that 
approximately 75% of the cases had CAD or CAD with concurrent CAFR. 
Gastrointestinal signs were recorded more frequently in the medical records of 
individuals that subsequently responded to diet trials. However, this was not 
strong enough as a discriminating factor to utilize for predicting which of the 
animals that had not undergone such testing were likely to have CAFR. 
 
In the examined insurance database, it was concluded that the correctness 
(whether the recorded cases actually have the disease) of the diagnosis CAD was   23 
acceptable, while the completeness (proportion of diseased cases that were in fact 
recorded) was unknown but most likely low. Furthermore, all recorded cases were 
coded by the submitting veterinarian to have CAD and therefore the information 
was accurate regarding the transfer of diagnostic information from medical records 
to the insurance database. Internal validity was defined by Jordan et al. (2004) as 
whether the diagnosis perceived correct by the clinician is recorded in the 
database, and can in this case be classified as excellent. External validity was 
defined by the same authors as whether the patient has the disease coded by the 
examining practitioner, and relates to the diagnostic ability of the veterinarian as 
judged against an external standard (Jordan, Porcheret & Croft, 2004). By this 
definition, the external validity for the diagnosis CAD in the insurance database 
was questionable because some veterinarians did not appropriately exclude CAFR. 
 
As stated previously, it is important to validate secondary databases if they are 
to be utilized in research. Papers II and III rely on the information obtained in 
paper I. The results from this study confirm that CAD is a subjective diagnosis and 
that the quality of the work-up depends on the individual veterinarian. Jordan et al. 
(2004) performed a systematic review of validation studies to assess the quality of 
human morbidity coding in computerized general practice records. It was 
concluded that conditions with clear diagnostic criteria, such as diabetes, overall 
had better quality recordings than subjective diagnoses such as asthma (Jordan, 
Porcheret & Croft, 2004). The presented results for CAD are in agreement with 
this finding, and this needs to be kept in mind when interpreting the results from 
paper II and III. Most importantly, the proportion of recorded CAD patients that 
should actually be coded as CAFR positive or with a dual diagnosis of CAD and 
CAFR remains unknown. 
 
CAD incidence varies by breed (II) 
In paper II, the overall IR of CAD was calculated as 1.7 new cases per 1000 dog 
years at risk (DYAR). The 95% confidence interval (CI) for the estimate was 1.67 
to 1.77 cases per 1000 DYAR. For a relatively rare occurrence like CAD, the 
yearly incidence risk can be directly extrapolated from the IR to be 0.17% which 
means that an individual dog’s risk of developing CAD during a year is 0.17% 
(Dohoo, Martin, & Stryhn 2003a). The proportion of dogs with a recorded 
dermatologic diagnosis that were coded as having CAD was 5.1 %, which is in 
agreement with the result obtained by Hill et al. (2006) in Great Britain but is at 
the low end of the range of estimates published by other authors. It is believed that 
the true incidence of CAD is underestimated in the insured population due to the 
perceived low completeness of the database regarding the diagnosis. 
 
The performed study confirmed that breed is an important risk factor for CAD. 
The bullterrier had the highest IR of CAD with 21 (95% CI 15.6 – 26.4) cases per 
1000 DYAR. Other breeds at increased risk were the Welsh terrier, boxer and 
WHWT. Three of the top-risk breeds from paper II were selected for further 
sampling in paper IV. (The Welsh terrier was not included due to relatively few 
registered individuals of this breed in Sweden.) When looking at high-risk breeds   24
for disease from a national population, it should be noted that results cannot 
necessarily be extrapolated to other national populations because even purebreds 
might be genetically different across countries. However, several of the high-risk 
breeds presented in the current study have also been reported to be at increased 
risk by other authors, such as the Dalmatian, Labrador retriever, WHWT, boxer, 
German shepherd and bullterrier (Sousa & Marsella, 2001). 
 
With the recent sequencing of the canine genome, new opportunities to search 
for disease-causing or predisposing genes arise (Lindblad-Toh et al., 2005). Due to 
years of selective mating, individuals within the same canine breed share 
homologous genetic regions to a much greater extent than humans. These 
conserved regions of the canine genome are useful for comparative studies of 
genetic diseases, because many of the genetic diseases seen in humans such as 
diabetes, cancers, epilepsy and AD are also present among dogs. Furthermore, it is 
likely that the same risk allele is carried by multiple related breeds. Lindblad-Toh 
et al. (2005) therefore conclude that genome comparisons within and across breeds 
can reveal genes that underlie inherited traits and that association studies for 
almost any disease can be performed with today’s resolution of the canine genome 
sequence because of the high degree of homology. A subset of the included boxers 
and WHWTs were used to evaluate if a candidate gene for AD could be associated 
with CAD in dogs, but yielded negative results (Stenshamn et al., 2006). DNA 
collected from the presented cases and controls will be used for further genetic 
analyses in the future. 
 
Spatial patterns in the distribution of CAD cases (III) 
The crude incidence rate of CAD by PCA is presented as a choropleth map in 
figure 1. Figure 2 shows the spatially EB smoothed IR of CAD. The overall trend 
is that the IR is higher in the southern parts of the country and in densely 
populated areas. This becomes more obvious in figure 2 because the smoothing 
process provides more stable IR estimates in areas with small populations at risk 
by “shrinking” the individual rates towards their neighbourhood means (Bailey & 
Gatrell, 1995). 
 
Several factors were found to be associated with an increased risk of CAD 
through the spatial regression model; increasing human population density (HPD), 
increasing levels of average annual rainfall, the presence of a veterinary 
dermatologist in the county and living in the south of Sweden. Paper II also 
revealed city living as a risk factor for CAD, which is in agreement with the 
observation that the prevalence of AD among humans is increased with urban 
living. However, it was established in paper I that for a subjective diagnosis like 
CAD it will depend on the skills of the examining veterinarian whether a patient is 
correctly diagnosed or not. Many of the Swedish veterinarians that specialize in 
dermatology are located in densely populated areas and it cannot be ruled out that 
the effect of urban living in the current studies is an effect of practitioner rather 
than of the environment in the cities itself. The association between CAD and city 
living could not be confirmed in the case-control material when the effect of submitting veterinarian was controlled for, but the sample-size in this study was 
limited and there might have been insufficient power to detect a relationship. 
 
 
 
 
Figure 1. The crude incidence rate of canine atopic dermatitis per 1000 dog years at risk in 
Sweden between 1995 and 2002, by postal code area (n=559). 
 
The IR of CAD was lower for dogs living in the northern half of Sweden than in 
the south. In previous studies of overall morbidity (Egenvall et al., 2000b) and 
breed risk of pyometra (Egenvall et al., 2001), it was also concluded that disease 
occurrence was lower in the north. A possible explanation for this phenomenon is 
  25 that the canine population differs between regions in a way that favours 
“healthier” breeds in the north. It can further be speculated that there are less 
recorded claims in the north because there are fewer specialized veterinary clinics 
in this sparsely populated region of the country or that dog owners there are less 
likely to seek veterinary assistance. The spatial regression analysis was performed 
on IR data aggregated by PCA, and the breed or age-distribution of the population 
could therefore not be included in the model. 
 
 
Figure 2. The spatial Empirical Bayes smoothed incidence rate of canine atopic dermatitis 
per 1000 dog years at risk in Sweden between 1995 and 2002, by postal code area (n=559). 
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Finally, an increasing risk of CAD was seen with increasing levels of average 
annual rainfall. It was speculated that this could be due to more patients reaching 
their “pruritic threshold” due to exacerbation of clinical signs with increasing 
humidity, and hence being subject to examination by a veterinarian to a greater 
extent (Marsella & Sousa, 2001). Furthermore, increasing humidity might provide 
better conditions for HDM which could then act as a trigger for the development 
of CAD (Arlian, Neal & Vyszenski-Moher, 1999). 
 
Early diet and its effect on CAD occurrence (IV) 
In paper IV it was showed that feeding a home-made/non-commercial diet to the 
bitch during lactation significantly decreased the odds of her offspring becoming 
CAD positive in the three high-risk breeds bullterrier, boxer and WHWT. This is 
an interesting finding from a comparative point of view. The recent adjustments in 
the understanding of the “hygiene hypothesis” and the importance of gut micro-
flora for the modification of the immune response might be related to this effect of 
early dietary exposure (Flohr, Pascoe & Williams, 2005). The presented analysis 
did not include a breakdown of ingredients in the non-commercial diets, but it 
seems reasonable to assume that the content of micro-organisms in food prepared 
manually in the home would be higher than in commercial dog foods. It should be 
kept in mind that the diets did not have to consist exclusively of non-commercial 
ingredients to have a protective effect, the combination of home-made and 
commercial food also contributed to decreased odds of CAD. 
 
Studies in humans have showed a lower prevalence of AD in children exposed 
to unpasteurized milk (Perkin & Strachan, 2006), in Estonian versus Swedish 
children (Voor et al., 2005) and in children from families with an antroposophic 
lifestyle (Alfven et al., 2006). Björkstén et al. (2001) performed a prospective 
study and concluded that intestinal microflora in infants can play an important role 
in protection against allergy. Based on these, and several other, studies it has been 
suggested that the TH2 response associated with AD can be down-regulated 
through exposure to non-pathogenic micro-organisms which has lead to the recent 
focus on probiotics for primary prevention of the disease. However, the 
relationship between microbial exposure and development of AD is unlikely to be 
straightforward and issues like timing and magnitude of the exposure might 
modify the effect (Williams & Flohr, 2006).  
 
Only the association with diet during lactation was analyzed in the regression 
model, and no conclusions can be drawn about the effect of home-made diets 
during pregnancy. It is also important to note that pregnant and lactating 
individuals have special dietary requirements that need to be fulfilled regardless of 
the origin of their diet. Further research, preferably randomized controlled clinical 
trials, is needed before recommendations can be made about changing the diet of 
the pregnant and/or lactating bitch to prevent CAD in her offspring. 
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Other pre-disposing factors (II, IV) 
No effect of gender on the occurrence of CAD was detected in either of the two 
examined populations (paper II and paper IV). Based on this finding it seems 
reasonable to exclude gender from further discussions on risk factors for CAD. 
However, it is important to remember that the vast majority of Swedish dogs are 
intact and some caution should be exercised in extrapolating the result to other 
populations where neutering is routinely performed. 
 
Based on the analysis performed in paper II, it was confirmed that CAD occurs 
most commonly in young individuals. The hazard of a recorded CAD diagnosis 
was highest for dogs between one and five years of age. This interval might seem 
higher than the age of onset of six months to three years that has been reported in 
the literature (Griffin & DeBoer, 2001). However, due to complexity of 
diagnosing CAD there is likely to be a time-lag between first occurrence of 
clinical signs and a recorded CAD-diagnosis in the insurance database. 
 
In paper IV, white coat-colour was found to be a risk factor for CAD among the 
included bullterriers. Because the factor could only be investigated for one breed 
that consisted of very few individuals, no firm conclusions can be drawn about the 
association between coat colour and risk of CAD at the current stage and more 
studies are needed to further elucidate this issue. 
 
Papers II and IV include conflicting results regarding the effect of season of 
birth on the development of CAD. In the insured population (paper II), the risk of 
CAD was higher among individuals born during the fall months of October to 
December. Meanwhile, in the case-control population collected for paper IV no 
such effect was detected. In genetically predisposed humans, maternal exposure to 
allergen during late pregnancy can determine if the predisposition will be 
manifested as allergic disease in the offspring (Warner et al., 2000). Warner et al. 
(2000) further hypothesize that continued exposure to the same antigens in the 
newborn might reinforce this effect. Based upon these findings, it would appear 
that individuals born during seasons of high exposure to certain allergens could be 
at increased risk of developing an IgE response towards the same allergens. This 
issue needs to be investigated further for CAD.   29 
Conclusions 
•  The cases recorded with CAD in the Agria insurance database were all 
coded by the examining veterinarian to be CAD-positive. However, the 
diagnostic ability of some practitioners was questionable because adverse 
food reactions were not properly ruled out. Overall, around 75% of the 
cases were believed to have CAD. 
  
•  The incidence rate of CAD among insured Swedish dogs was estimated 
to 1.7 cases per 1000 dog years at risk (95% CI: 1.67 to 1.77). This 
estimate is probably conservative, due to the perceived low completeness 
of the insurance database regarding this diagnosis. 
 
•  Substantial variations in the incidence of CAD exist between breeds, with 
the bullterrier being at the highest risk in this material. 
 
•  It was confirmed that CAD is a diagnosis of young animals. 
 
•  No difference in the incidence of CAD was seen between genders in two 
Swedish populations of predominantly intact individuals. 
 
•  Conflicting results were achieved regarding the effect of season of birth 
on CAD incidence. In the insured population, an increased incidence was 
seen for individuals born in the fall but this finding could not be 
confirmed through the case-control study. 
 
•  Two studies suggest that geographical variations in CAD incidence exist 
in Sweden. Living in a densely populated or humid area was associated 
with increased risk of the disease. However, the results might be biased 
by the geographical distribution of different breeds of dogs in Sweden, or 
by the location of the examining veterinarian because of the subjective 
nature of the diagnosis. 
 
•  A preventive effect of feeding a home-made/non-commercial diet to the 
lactating bitch on subsequent development of CAD in her offspring was 
observed for the high-risk breeds boxer, bullterrier and West Highland 
white terrier.    30
Implications for future research 
New insight has been gained regarding the epidemiology of canine atopic 
dermatitis through the described studies. However, several areas have been 
identified in which further research is needed: 
 
A formal validation of the diagnostic criteria for CAD should be conducted, 
including calculation of sensitivity and specificity. 
 
Spatial analysis on non-aggregated data would be a valuable addition to the 
existing study on geographical risk factors for CAD because it would allow taking 
breed, age and actual distance to a veterinary dermatologist into account. 
 
The evidence supporting season of birth as a risk factor for CAD needs to be 
further investigated, as conflicting results were seen between the case-control 
study and the incidence rate study based on insurance data. 
 
Focused studies are needed in order to determine if white coat-colour, or genes 
regulating coat-colour, are relevant risk factors for CAD. Genetic studies to 
identify other genes (or genetic regions) of importance for the development of 
CAD among high-risk breeds might also increase our knowledge regarding the 
disease. 
 
Randomized controlled clinical trials are needed to confirm the results from the 
case-control study suggesting that primary prevention of CAD can be achieved 
through modification of the diet used for bitches during lactation. 
   31 
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